News on immunoassay systems and applications.
The Swedish firm Biovica said this and additional studies will form the basis of a US Food and Drug Administration submission for its test measuring thymidine kinase-1.
CEO Prahlad Singh said the firm is developing a PCR- and antibody-based assay for the novel coronavirus 2019-nCoV and is working with the Chinese NMPA.
Natera discussed its cancer and transplant rejection testing businesses, while Exact Sciences explained how it will benefit from its Genomic Health acquisition.
CE marking of PromarkerD Hub complements the CE mark that the mass spectrometry version of the test received in November.
Abbott highlighted its next-generation Alinity platforms, and Caris discussed its plans to provide precision oncology services.
